Showing results (341-350 of 743) with videos related to
Sort By:
Pageof 75
Clinical Journal of the American Society of Nephrology : CJASN|August 19, 2007
Severity of baseline proteinuria predicts renal response in immunoglobulin light chain-associated amyloidosis after autologous stem cell transplantationNelson Leung, Angela Dispenzieri, Martha Q Lacy, et al.British Journal of Haematology|April 16, 2008
Prediction of survival using absolute lymphocyte count for newly diagnosed patients with multiple myeloma: a retrospective studyHilmi Ege, Morie A Gertz, Svetomir N Markovic, et al.Advances in Therapy|March 18, 2024
Adjusted Indirect Treatment Comparison of Progression-Free Survival with D-Rd and VRd Based on MAIA and SWOG S0777 Individual Patient-Level DataBrian G M Durie, Shaji K Kumar, Eric M Ammann, et al.Cancer Science|May 10, 2007
Serum M-spike and transplant outcome in patients with multiple myelomaDavid Dingli, Jorge M Pacheco, Angela Dispenzieri, et al.Cancer|November 22, 2022
Sarcopenia identified by computed tomography imaging using a deep learning-based segmentation approach impacts survival in patients with newly diagnosed multiple myelomaBharat Nandakumar, Francis Baffour, Nadine H Abdallah, et al.American Journal of Hematology|December 24, 2019
Enhancing the R-ISS classification of newly diagnosed multiple myeloma by quantifying circulating clonal plasma cellsWilson I Gonsalves, Dragan Jevremovic, Bharat Nandakumar, et al.Blood Advances|August 5, 2020
Clinical characteristics and treatment outcomes of newly diagnosed multiple myeloma with chromosome 1q abnormalitiesNadine Abdallah, Patricia Greipp, Prashant Kapoor, et al.Leukemia|October 14, 2024
Functional variant rs9344 at 11q13.3 regulates CCND1 expression in multiple myeloma with t(11;14)Hongwei Tang, Huihuang Yan, Suganti Shivaram, et al.Blood|October 22, 2024
Comparison of progression risk of monoclonal gammopathy of undetermined significance by method of detectionAlissa Visram, Dirk Larson, Aaron Norman, et al.Oncotarget|August 6, 2016
Smac mimetic LCL161 overcomes protective ER stress induced by obatoclax, synergistically causing cell death in multiple myelomaVijay Ramakrishnan, Marcus Gomez, Vivek Prasad, et al.Pageof 75